Startup ASEAN

Biocheetah PTE. LTD.

View Website

Related Keywords

ACTIVE Healthcare & Education Biotechnology

Headquarter Location

79 AYER RAJAH CRESCENT #05-09 Singapore 139955

Company Profile BioCheetah is a Singapore-based, Agency Science Technology and Research(A*STAR)-Institute of Molecular and Cell Biology(IMCB) spin-off company. It is primarily set up to develop and commercialize non-invasive, protein-based immunodiagnostic applications. First diagnostic applications in development are based on the proprietary bladder cancer biomarkers and detection antibodies discovered and developed in IMCB by BioCheetah’s Scientific Founder (Prof. Jean-Paul Thiery) and the co-Founder/Chief Executive Officer (Dr. Kian-Chung Lee).Products to be developed include professional use in-vitro diagnostic ELISA and Point-of-care test (POCT) kits. The kits will employ a novel multiplex urine-based biomarkers panel with high sensitivity and specificity for diagnosis and monitoring of bladder cancer.There are several clinical trials for clinical validation of the bladder cancer diagnostic products is currently underway locally and with several hospitals worldwide.

Overview

Website

https://www.biocheetah.com/

kclee@biocheetah.com

Founded Date

2018-10-22

Company Size

Company Stage

Industry

Healthcare & Education

Technology

Biotechnology

Client Focus

B2B

Status

ACTIVE

Headquarter Location

79 AYER RAJAH CRESCENT #05-09 Singapore 139955